Pricing Table
Kit Size | Dosage per Vial | Total Peptide | Your Price | Price per mg |
---|---|---|---|---|
10 Vials | 5mg | 50mg | $300 | $6.00/mg |
10 Vials | 10mg | 100mg | $430 | $4.30/mg |
Quick Product Specs
- Purity: ≥98% (HPLC Verified)
- Form: Lyophilized Powder
- CAS Number: 923950-08-7
- Molecular Formula: C₂₆₄₈H₄₀₄₄N₆₇₂O₈₃₆S₈
- Storage: -20°C (freezer)
- Shelf Life: 24 months unopened
- Type: Long-Acting GLP-1 Receptor Agonist
- Half-Life: ~5 days (allows weekly dosing)
What is Dulaglutide?
Dulaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist designed for once-weekly administration. It consists of two identical disulfide-linked chains, each containing a modified GLP-1 analog covalently linked to a human immunoglobulin G4 (IgG4) Fc fragment. This unique structure provides an extended half-life of approximately 5 days, allowing for convenient weekly dosing in research protocols. Dulaglutide works by activating GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite.
Unlike daily GLP-1 agonists (like liraglutide), dulaglutide’s extended release formulation makes it particularly valuable for studying long-term metabolic effects and improving research protocol compliance. It has been extensively studied for type 2 diabetes management, weight reduction, cardiovascular protection, and metabolic syndrome.
Research Applications
- Weekly GLP-1 receptor activation studies
- Long-acting peptide delivery mechanism research
- Glucose metabolism and glycemic control investigation
- Weight management and obesity research with reduced dosing frequency
- Cardiovascular outcome and protection studies
- Patient compliance and convenience protocol research
- Comparison studies: weekly vs daily GLP-1 agonist efficacy
- IgG4 Fc fusion protein technology research
- Sustained appetite suppression mechanism investigation